Commentary on "Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa": Small molecule factor XIa inhibitor asundexian allows for safer anticoagulation.

Published in: Journal of thrombosis and haemostasis : JTH (2022)

Keyphrases